Carbohydrate-based Vaccine Development

CD BioGlyco provides an integrated solution to develop carbohydrate-based vaccines according to each customer's scientific needs. We have various advanced technology platforms and high-quality services to meet your requirements. We are confident to be your essential research assistant in the field of glycobiology.

We focuses on carbohydrate-based vaccine development for several years. Our services are divided into polysaccharide vaccine development, tumor-related carbohydrate vaccine development, and glycoconjugate vaccine development by type. According to the sources of carbohydrates, our services include vaccine development of natural carbohydrates, semi-synthetic carbohydrates, and fully synthetic carbohydrates. According to the applications, we provide antibacterial, antifungal, antiparasitic, antiviral, anticancer, and antihelminthic vaccine development. By valent category, we provide monovalent and polyvalent carbohydrate-based vaccine development.

In addition, CD BioGlyco provides customers with carrier protein design services and carbohydrate conjugation services for vaccine development.

Fig.1 Carbohydrate-based vaccines against a variety of diseases. (Morelli, 2011)

By Type

By Source

By Application

By Valent

Carrier Protein Design Service

We provide customers with a wide range of high-quality carrier proteins synthesis services as well as specialized design services for new carrier proteins for the development of glycoconjugate vaccines.

Carbohydrate Conjugation Service for Vaccine Development

CD BioGlyco has extensive experience in carbohydrate-based vaccine development. We offer a wide range of carbohydrate conjugation services for vaccine development according to our clients' scientific needs.

Advantages of Us

• Advanced technology platform capable of purifying antigens from complex samples
• Multiple synthesis methods are available
• Systematic operation and powerful analysis platform
• Provide multiple protein carriers
• Customize experimental programs according to different research needs

CD BioGlyco is committed to providing high-quality carbohydrate-based vaccine design and synthesis services to promote our clients' vaccine development projects. Our experienced scientific research personnel will customize a rational program according to your needs, and finally, obtain carbohydrate antigens with a certain structure and high immunogenicity. If you are interested in our services, please contact us for more detailed information.

References:

1. Mettu, R.; et al. Synthetic carbohydrate-based vaccines: challenges and opportunities. Journal of Biomedical Science. 2020, 27(1).
2. Morelli, L.; et al. Carbohydrates and immunology: synthetic oligosaccharide antigens for vaccine formulation. European Journal of Organic Chemistry. 2011, 29: 5723-5777.